USPTO serial 86920020
Reviewed by CopyMark Law Group
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Plus Government fees of $2,600
Woonsocket, RI, US
Woonsocket, RI, US
Woonsocket, RI, US
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Erich G. Rhynhart
Erich G. Rhynhart CVS PHARMACY, INC.ONE CVS DRIVEMAIL CODE: 1160WOONSOCKET, RI 02895| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Medical referrals; managed care services, namely, electronic processing of health care and pharmaceutical information; procurement, namely, purchasing pharmaceuticals for others; supplying prescription drugs to health plan participants for the funding organizations | ACTIVE | Mar 18, 2016 |
| 036 | Insurance claims administration for medical claims and pharmaceuticals; processing of insurance claims and payment data | ACTIVE | Mar 18, 2016 |
| 041 | Medical educational services, namely, providing courses of instruction in the medical fields of parenteral and enteral therapy and intraperitoneal therapy and treatment; medical education services namely, training for medical professionals and patients regarding the use and application of enteral and parenteral therapy for medical purposes and distributing course materials in connection therewith; medical educational services, namely, providing individualized and group instruction, seminars and workshops for patients and caregivers of patients requiring parenteral and enteral therapy for medical purposes | ACTIVE | Aug 19, 2016 |
| 044 | Medical services, namely, providing therapy management services relating to the provision of in-home and ambulatory infusion therapies and nutritional services; Medical services, namely, infusion services provided at home and in clinics; nursing services; providing medical information concerning hemophilia; Providing in-home and ambulatory dispensing and administering of infusion pharmaceuticals, and providing hemophilia, anti-infectives, pain remediation, palliative care, cardiac, inotropic, antitrypsin deficiency, pre-transplant, post-transplant, growth hormone, hepatitis, osteoarthritis, steroid, immune deficiency, rheumatoid arthritis, multiple sclerosis, interferon, alcohol dependency, oncology, fertility, vaccine and nutritional therapy services | ACTIVE | Mar 15, 2016 |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| May 16, 2026 | REM2 | COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED | — |
| Nov 11, 2023 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Nov 10, 2023 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Nov 9, 2023 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| May 12, 2023 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| May 16, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| May 16, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 11, 2017 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Apr 10, 2017 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Mar 16, 2017 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Mar 14, 2017 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Mar 2, 2017 | IUAF | USE AMENDMENT FILED | — |
| Mar 2, 2017 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Sep 6, 2016 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 12, 2016 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 12, 2016 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jun 22, 2016 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 9, 2016 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Jun 1, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 18, 2016 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 16, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 16, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Mar 9, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Mar 1, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 29, 2016 | NWAP | NEW APPLICATION ENTERED | — |